Sort
35,931 grants matching “parkinsons”
Genetically encoded indicators for large-scale sensing of neuromodulatory signaling in behaving animals
$960,752Lin Tian · University Of California At Davis · U01 · FY2019 · NS
Toxicology in the 21st Century Program (Tox21) - Genomic Toxicology
$960,480David Gerhold · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease
$959,860Rima F Kaddurah-Daouk · Duke University · U19 · FY2023 · AG
Function and Pathogenic Mechanism of LRRK2 in Parkinson's Disease
$959,080Huaibin Cai · National Institute On Aging · ZIA · FY2018 · AG
Mechanisms of Manganese Neurotoxicity
$958,449Michael Aschner · Albert Einstein College Of Medicine · R01 · FY2015 · ES
Development of STEP Allosteric Inhibitors as Novel Therapeutics for Alzheimer's Disease
$958,279Lutz Tautz · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AG
Design And Development Of Experimental Therapeutics
$958,195Nigel H. Greig · National Institute On Aging · ZIA · FY2013 · AG
Treating Agitation/Psychosis in Dementia/Parkinsonism
$958,094University Of Rochester · R01 · FY2003 · AG
Neurostimulation by Ultrasound: Physical Biophysical and Neural Mechanisms
$958,010Merritt C Maduke · Stanford University · R01 · FY2023 · NS
Decode Mitochondrial Morphology Dynamics to Predict Cell Fate Decisions
$957,500Johannes Schoeneberg · University Of California, San Diego · DP2 · FY2025 · GM
Clinical Core B
$956,997Douglas R Galasko · University Of California, San Diego · P50 · FY2010 · AG
Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder
$956,407Parag Gad · Spinex, Inc. · R44 · FY2021 · DK
Wide Deployment of Massively Multiplexed Nanosystems for Brain Activity Mapping
$955,773Michael L Roukes · California Institute Of Technology · U01 · FY2018 · NS
Neural mechanisms of gait disturbances as individualized digital biomarker trajectories in preclinical dementia
$955,432Ehsan Adeli · Stanford University · R01 · FY2024 · AG
Multi-site longitudinal Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)
$955,309Chris Berka · Advanced Brain Monitoring, Inc. · R44 · FY2024 · AG
Mechanisms of Manganese Neurotoxicity
$954,883Michael Aschner · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · ES
Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies
$954,862Todd Levine · Cnd Life Sciences, Inc. · R44 · FY2024 · NS
Project III "Cognitive Difficulty in LB and AD Dementias"
$954,391Murray Grossman · University Of Pennsylvania · U19 · FY2022 · AG
Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson's Disease Trials-2 (AT-HOME PD-2)
$954,355Ruth Schneider · University Of Rochester · R01 · FY2024 · NS
NEUROSCIENCE CORE CENTER
$954,269Francis W Flynn · University Of Wyoming · P30 · FY2013 · GM
Long-term toxicology studies for Posiphen; 6 month in rats and 9 months in dogs
$953,849Maria Maccecchini · Annovis Bio, Inc. · U01 · FY2019 · AG
Delivery of peptides for inducing voiding associated with neurological retention
$953,265Lesley Marson · Dignify Therapeutics, Llc · R42 · FY2016 · NS
Genetically encoded indicators for large-scale sensing of neuromodulatory signaling in behaving animals
$953,117Lin Tian · University Of California At Davis · U01 · FY2018 · NS
Cutaneous Phosphorylated Alpha-Synuclein for Detection of Prodromal Synucleinopathies
$952,525Todd Levine · Cnd Life Sciences, Inc. · R44 · FY2023 · NS
Genetic Silencing of Striatal CaV1.3 Calcium Channels as a Potent Antidyskinetic Therapy for PD
$952,368Kathy Steece Steece-Collier · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2024 · NS